- Filed
- Jul 23, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 19, 2024 | 31M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $510.89M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $245.45M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $993.09M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $925.13M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $1.16B |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $1.1B |
| Current Assets | Q2 2024 · Jun 30, 2024 | $872.52M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $593.83M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $1.92B |
| Total Assets | Q2 2024 · Dec 31, 2023 | $1.66B |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 31.58M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 31.86M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $144.02M |
| Capex | Q2 2024 · Jun 30, 2023 | $17.96M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $162.59M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $391.06M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $347.26M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $386.39M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $1.93 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $4.20 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $2.00 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $4.35 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $39.4M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $77.43M |
| Net Income | Q2 2024 · Jun 30, 2023 | $61.07M |
| Net Income | Q2 2024 · Jun 30, 2023 | $133.96M |
| Net Income | Q2 2024 · Mar 31, 2023 | $72.89M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $78.39M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $164.6M |
| Revenue | Q2 2024 · Jun 30, 2023 | $460.87M |
| Revenue | Q2 2024 · Jun 30, 2023 | $894.94M |